Evidence map›Paper›PMID 25813713›Full record

ArticleNeuroscience2015

Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats.

P S S Rao, S Goodwani, R L Bell, Y Wei, S H S Boddu, Y Sari

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Influence of glutamate and GABA transport on brain excitatory/inhibitory balance.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Glial mechanisms underlying substance use disorders.The European journal of neuroscience · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse.The international journal of neuropsychopharmacology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

P S S RaoUniversity of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacology, Toledo, OH, USA.
S GoodwaniUniversity of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacology, Toledo, OH, USA.
R L BellIndiana University School of Medicine, Department of Psychiatry, Indianapolis, IN, USA.
Y WeiUniversity of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, Toledo, OH, USA.
S H S BodduUniversity of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, Toledo, OH, USA.
Y SariUniversity of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacology, Toledo, OH, USA. Electronic address: youssef.sari@utoledo.edu.
University of Toledo · USIndiana University School of Medicine

Funding

Translational Research and Science Education (OUT)P60AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Marian Lee Logrip · 2003 to 2026
$45.5M
Rat Animal Models Core (RAMC)U01AA013522 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BELL, RICHARD LOWELL · 2001 to 2014
$4.3M
Rodents with Genetic Differences in Alcohol PreferenceU24AA015512 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI BELL, RICHARD LOWELL · 2015 to 2019
$2.7M
Rat Animal Models & Drug and Gene Testing Core (RAM-DGTC)U24AA013522 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI BELL, RICHARD LOWELL · 2015 to 2021
$2.4M
The role of GLT1 in the modulation of alcohol-drinking behavior in P rats.R01AA019458 · NIAAA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SARI, YOUSSEF · 2011 to 2015
$1.1M
NIAAA NIH HHS AA13522NIAAA NIH HHS P60 AA007611NIAAA NIH HHS R01 AA019458NIAAA NIH HHS U01 AA013522NIAAA NIH HHS U24 AA013522NIAAA NIH HHS U24 AA015512
6 · The paper itself

Abstract

Chronic ethanol consumption is known to downregulate expression of the major glutamate transporter 1 (GLT-1), which increases extracellular glutamate concentrations in subregions of the mesocorticolimbic reward pathway. While β-lactam antibiotics were initially identified as potent upregulators of GLT-1 expression, only ceftriaxone has been extensively studied in various drug addiction models. Therefore, in this study, adult male alcohol-preferring (P) rats exposed chronically to ethanol were treated with other β-lactam antibiotics, ampicillin, cefazolin or cefoperazone (100mg/kg) once daily for five consecutive days to assess their effects on ethanol consumption. The results demonstrated that each compound significantly reduced ethanol intake compared to the saline-treated control group. Importantly, each compound significantly upregulated both GLT-1 and pAKT expressions in the nucleus accumbens and prefrontal cortex compared to saline-treated control group. In addition, only cefoperazone significantly inhibited hepatic aldehyde dehydrogenase-2 enzyme activity. Moreover, these β-lactams exerted only a transient effect on sucrose drinking, suggesting specificity for chronically inhibiting ethanol reward in adult male P rats. Cerebrospinal fluid concentrations of ampicillin, cefazolin or cefoperazone have been confirmed using high-performance liquid chromatography. These findings demonstrate that multiple β-lactam antibiotics demonstrate efficacy in reducing alcohol consumption and appear to be potential therapeutic compounds for treating alcohol abuse and/or dependence. In addition, these results suggest that pAKT may be an important player in this effect, possibly through increased transcription of GLT-1.

Indexed as

Alcohol DrinkingAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialAmpicillinAnimalsAnti-Bacterial AgentsBody WeightCefazolinCefoperazoneCentral Nervous System DepressantsConditioning, OperantDrinkingEthanolExcitatory Amino Acid Transporter 2Food PreferencesMaleAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialAldh2 protein, ratAmpicillinAnti-Bacterial AgentsCefazolinCefoperazoneCentral Nervous System DepressantsEthanolExcitatory Amino Acid Transporter 2Mitochondrial ProteinsOncogene Protein v-aktSlc1a2 protein, ratSucroseSweetening Agentsalcohol intakeampicillincefazolincefoperazoneEAAT2glutamate

Identifiers

PMID25813713
PMCPMC4408259
OpenAlexW2045857710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.